Advancements in science and medicine are continuing to grow year by year, Dr. Patel strives to grow along side with continuing his education and training with the newest treatment options available.

Stem Cell Therapy helps to create new cells in existing healthy tissues and may help to repair tissues in those structures that are injured or damaged.

Stem cell procedures are being used and tested in hundreds of ways from Nuerological regeneration to the curing of diseases. Within these hundreds of treatment, testings include: 

  1. Regenerating articular cartilage in arthritic joints
  2. Increased healing bone fractures and nonunions
  3. Healing ligaments or tendons injuries


For many patients with debilitating knee osteoarthritis, treatment options are limited and include steroid injections, hyaluronic acid injections (viscosupplementation), physical therapy, and joint replacement surgery. Rotator cuff tendonitis is also a common problem and again, treatment is often limited to intermittent steroid injections, physical therapy and possibly surgery when conservative management fails. Steroid injections have frequently been met with either ineffectiveness, short-term pain relief and the risk of tendon atrophy and rupture. Currently, Dr. Jignesh Patel, DO offers new cutting-edge treatment options like amniotic membrane stem cell injections which can be used to as an alternative to surgery to successfully treat patients with degenerative arthritis (knee and shoulder), rotator cuff tendonitis, lateral epicondylitis (tennis elbow) and other tendon and joint disorders.

For clarification, this type of stem cell comes from the amniotic sac of donated placentas following childbirth – it is not embryotic. The amnion is removed and harvested from the placenta of prescreened and tested donors. It is then sterilely processed and undergoes further rigorous testing to assure safety and efficacy. While some people may have ethical issues with embryonic stem cell therapy, most everyone agrees that the use of amniotic stem cell therapy raises no ethical or moral questions. This is also an FDA approved product.


Yes. Amniotic stem cell treatment has been used by ophthalmologists to aid with corneal surgery for over 20 years. It also has applications in plastic surgery assisting in burn patient healing. To date, more than 10,000 injections have been performed without a single reported adverse side effect. As with all treatment options, the biggest risk of a stem cell injection is that it does not alleviate all your pain but does afford one more option prior to surgical intervention.

Amniotic stem cell therapy is a preferred type of stem cell therapy because the cells come from an immunoprivileged site (newborn babies). This means that patient-rejection is extremely rare.
The use of amniotic stem cells is well researched, safe, and effective.
All amniotic stem cell donors go through a rigorous screening process, as determined by the Food and Drug Administration (FDA) and American Association of Tissue Banks (AATB).


Patients suffering from any kind of joint, tendon, or ligament pain may be considered as candidates for amniotic stem cell therapy. Patients with severe degenerative osteoarthritis may not be eligible for stem cell therapy. Upon evaluation, Your physician may be able to provide you with recommendations for other types of treatment options.


Most insurance companies do not cover Amniotic Tissue injections at this time. As such, this is fee for service due at the time of treatment. Many insurance companies, however, may cover the initial consultation as well as some aspects of the treatment, such as the injection fee, radiographs, and use of ultrasound guidance if necessary during your appointment. 


Amnio Technology products do not require fetal sacrifice and recovery is performed with maternal consent during live birth. Placental tissues are collected at several facilities around the country, following strict guidelines and consistent with industry best practices.

Donors are healthy women between the ages of 18-45 years. A careful medical and social history is collected in advance to ensure mothers meet all eligibility requirements. Donors are thoroughly screened for communicable diseases.

An advancement in regenerative medicine, the Amnio Technology line of products are made from human amniotic membrane and fluid. These amniotic tissues, or allografts, are transplanted to provide protection and support for native tissues in the body.

The amniotic membrane is the innermost layer of the placenta which nourishes and maintains an unborn child. Amniotic fluid is the liquid that surrounds the baby until delivery. Just as these tissues provide biologic and physiologic properties and act as a physical barrier to cover and protect the fetus during pregnancy, the Amnio Technology line of products provide a biological, physiological and physical overlay to support and protect an injury in the body.

Amniotic tissues contain a unique mix of bioactive substances such as collagen, cell adhesion molecules and growth factors recognized as important in the wound healing process¹. Published studies on the benefits and efficacy of amniotic tissue in wounds date back over 100 years².

Amniotic fluid is known to contain multiple cell types derived from the developing fetus. Cells within this heterogeneous population can give rise to diverse differentiated cells including those of adipose, muscle, bone and neuronal lineages.

Amniotic tissue has reported anti-inflammatory, anti-bacterial and anti-fibrotic properties³. Amniotic tissues are also thought to have “immune privilege”, reducing the risk of an adverse immune reaction.

All of these characteristics make amniotic allografts an attractive biomaterial.